Randomized Population-Based Study on Chlamydia Trachomatis Screening

checkorphan
Learn more about:
Ectopic pregnancy
Related Clinical Trial
Medical Treatment in Ectopic Tubal Pregnancy Evaluation of Different Doses of Letrozole in Ectopic Pregnancy Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment. Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task Expectant Management of Ectopic Pregnancy Psychological Impact of Pregnancy of Unknown Location Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus Cornual Wedge Resection Outcome Pregnancies of Uncertain Location or Viability Research Randomized Population-Based Study on Chlamydia Trachomatis Screening Sonographic Assessment and Visualization of Ectopics in Emergency Medicine Kisspeptin Levels in Early Pregnancy RCT for Women With a Persisting Pregnancy of Unknown Location Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy Vitamin D in Ectopic Pregnancies Laparoscopic Tubal Preservation Surgery BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Methotrexate Treatment for Ectopic Pregnancy Comparison of Two Different Approaches in the Surgical Treatment of Tubal Ectopic Pregnancy Two-Dose Methotrexate for Ectopic Pregnancy Ectopic Pregnancy Biomarkers The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy? Risk Factors of Ectopic Pregnancy Assessment of Biomarkers in Ectopic Pregnancy Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF

Brief Title

Randomized Population-Based Study on Chlamydia Trachomatis Screening

Official Title

Populationbased Screening for Urogenital Chlamydia Trachomatis Infections by Use of Home-Obtained and Mailed Samples: A Randomized Study

Brief Summary

      30,000 individuals living in Aarhus County, Denmark by Oct 1997 were randomized into two
      groups. The intervention group received an invitation to be tested for urogenital Chlamydia
      trachomatis by use of home-obtained and mailed sample (9,000 individuals). The control group
      received no intervention (21,000 individuals). Outcome measures: Number of tested
      individuals, number of detected infections, number of women developing PID, ectopic pregnancy
      or infertility, number of women giving birth to a child, number of women receiving IVF
      treatment and number of men developing epididymitis.

      The hypothesis was that more individuals would be tested and treated for infections and that
      number of long term fertility complications would decline in the intervention group compared
      to control group.

Study Type

Interventional

Primary Outcome

Long term infertility complications

Condition

Chlamydia Trachomatis

Intervention

Screening for urogenital Chlamydia trachomatis

Study Arms / Comparison Groups

 1 Screening
Description:  Individuals receiving an invitation to be tested for urogenital Chlamydia trachomatis by use of a home-obtained and mailed sample.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Behavioral

Estimated Enrollment

30000

Start Date

October 1997

Completion Date

August 2007

Primary Completion Date

February 1998

Eligibility Criteria

        Inclusion Criteria:

          -  born in 1974, 1974 or 1976 AND living in Aarhus County October 1007

        Exclusion Criteria:

        -

Gender

All

Ages

21 Years - 24 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Berit Andersen, MD, Ph.D., ,

Location Countries

Denmark

Location Countries

Denmark

Administrative Informations

NCT ID

NCT00827970

Organization ID

Cesoirs01

Study Sponsor

University of Aarhus

Collaborators

 Aarhus County, Denmark

Study Sponsor

Berit Andersen, MD, Ph.D., Principal Investigator, Aarhus University Hospital Skejby, Department of Infectious Diseases

Verification Date

January 2009